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Abstract
Background: Campylobacter jejuni is a major cause of gastroenteritis worldwide. In Thailand, several strains of
C. jejuni have been isolated and identified as major diarrheal pathogens among adult travelers. To study the
epidemiology of C. jejuni in adult travelers and U.S. military personnel with acute diarrhea in Thailand from
1998-2003, strains of C. jejuni were isolated and phenotypically identified, serotyped, tested for antimicrobial
susceptibility, and characterized using pulsed-field gel electrophoresis (PFGE).
Results: A total of 312 C. jejuni isolates were obtained from travelers (n = 46) and U.S. military personnel (n = 266)
in Thailand who were experiencing acute diarrhea. Nalidixic acid and ciprofloxacin resistance was observed in
94.9% and 93.0% of the isolates, respectively. From 2001-2003, resistance to tetracycline (81.9%), trimethoprim-
sulfamethoxazole (57.9%), ampicillin (28.9%), kanamycin (5.9%), sulfisoxazole (3.9%), neomycin (2.0%), and
streptomycin (0.7%) was observed. Combined PFGE analysis showed considerable genetic diversity among the
C. jejuni isolates; however, four PFGE clusters included isolates from the major Lior serotypes (HL: 36, HL: 11, HL: 5,
and HL: 28). The PFGE analysis linked individual C. jejuni clones that were obtained at U.S. military exercises with
specific antimicrobial resistance patterns.
Conclusions: In summary, most human C. jejuni isolates from Thailand were multi-resistant to quinolones and
tetracycline. PFGE detected spatial and temporal C. jejuni clonality responsible for the common sources of
Campylobacter gastroenteritis.
Background
Campylobacter jejuni is a major cause of gastroenteritis
worldwide, especially in children, travelers, and military
personnel deployed to developing countries [1-4]. In
recent years, a high prevalence of infection and an
increased resistance to the antimicrobials used to treat
diarrhea have been documented [5,6]. C. jejuni and
C. coli can be phenotypically characterized by growth
characteristics, biochemical reactions, and hippurate
hydrolysis [7]. Serotyping techniques for C. jejuni and
C. coli have been developed [8-10]. Molecular
techniques such as RFLP, RAPD, PFGE, AFLP, and
MLST have also been applied to C. jejuni isolate charac-
terization [11].
PFGE is a well-known technique standardized by the
Centers for Disease Control and Prevention (CDC) for
subtyping Salmonella spp., Shigella spp., and Vibrio
spp., in addition to C. jejuni [12,13]. Unlike other
enteric bacteria, Campylobacter is a genetically diverse
organism that undergoes intra- and inter-genomic
exchange. However, PFGE is considered to be the most
discriminatory method of characterizing C. jejuni and
C. coli and identifying specific Campylobacter spp. in
outbreak studies [14-16]. Furthermore, the combination
of PFGE and other typing techniques can identify
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infections [17-19].
In Thailand, C. jejuni was isolated and identified as a
major diarrheal pathogen among children and adult tra-
velers, including U.S. military personnel [20-23]. A high
prevalence of infection with fluoroquinolone-resistant
C. jejuni was previously reported in both Thai children
and U.S. military personnel [3,24]. However, epidemiolo-
gical data on Campylobacter infection among travelers
and expatriates as well as their susceptibility to other
antimicrobials have not been described in Thailand in
several years. This prompted us to investigate and char-
acterize the C. jejuni isolates responsible for gastroenter-
itis in adult travelers by combining antimicrobial
resistance data, serotype classification, and PFGE.
Results and Discussion
Frequency and distribution of C. jejuni serotypes
From a total of 312 C. jejuni isolates obtained in this
study, 266 isolates were from U.S. soldiers and 46 were
from foreign travelers seen at Bumrungrad Hospital,
Bangkok. The prevalence of C. jejuni from diarrheal
cases was detected as 11.0% (46/417) in the Bumrungrad
Hospital study and 30.4% (266/875) in samples from
U.S. military personnel in the Cobra Gold exercises of
1998-2003 (Table 1). Overall, a total of 16 Lior serotypes
were detected; the three most common serotypes were
HL: 36, HL: 11, and HL: 5; these serotypes accounted
for 25.0% (78/312), 13.8% (43/312), and 7.4% (23/312) of
all of the isolates, respectively. Untypable strains com-
posed 17.6% (55/312) of the isolates. The distribution of
the serotypes and the incidence of C. jejuni isolates
among foreign travelers and U.S. military personnel are
s h o w ni nT a b l e2 .T h et w om o s tc o m m o ns e r o t y p e sb y
study location and year are shown in Table 1.
The incidence of the serotypes described herein were
included from the first to tenth ranks among the global
isolates [25] but were slightly different from those
reported previously in Thai children [24]. For example,
serotype HL: 5 was detected infrequently among Thai
children [24]. In this study, serotype HL: 5 was more
common, and serotypes HL: 9 and HL: 2 were less com-
m o n .T h em a j o r i t yo fC. jejuni isolates from serotype
HL: 5 (11/23) were isolated in 2001, and most C. jejuni
HL: 19 isolates (15/17) were obtained in 1999. The
untypable isolates comprised 54.3% (25/46) of the iso-
lates from foreign travelers in 2001-2002 compared to
11.3% (30/266) of the isolates from U.S. military person-
nel in this study. The adult travelers from Bumrungrad
Hospital spanned several nationalities, including Japa-
nese, European, American, and Australian. The high
percentage of untypable isolates might reflect the diverse
foods consumed by these travelers, while the low per-
centage of untypable isolates in the military personnel
might reflect the limited diet consumed by U.S. military
personnel on deployment.
PFGE analysis of C. jejuni isolates
At an 80% similarity level, a dendrogram combining
data for all 312 C. jejuni isolates from Thailand was
clustered into 62 genotypes (Figure 1). Four major geno-
types composed 49.7% (155/312) of the C. jejuni isolates
in this study, and 30 of the 62 genotypes included only
as i n g l eC. jejuni isolate. Of the 55 isolates that were
untypable by Lior serotyping, 42 could be grouped into
a genotype with other known serotypes.
Antimicrobial susceptibility tests
In 1998-2003, 94.9% (296/312) and 93.0% (289/311) of
the isolates were resistant to quinolones (NAL and CIP),
but 99.0% (306/309) were susceptible to macrolides
(ERY and AZM). The high prevalence of quinolone
(NAL and CIP) resistance and macrolide (ERY and
AZM) sensitivity is consistent with previously reported
results from Thailand [21,24,26]. For the 138 C. jejuni
isolates from 2001-2003, the percentages of resistant iso-
lates detected were as follows (Table 3): CF, 100% (138/
138); TE, 81.9% (113/138); SXT, 58.0% (80/138); AMP,
30.4% (42/138); KM, 6.5% (9/138); SU, 3.6% (5/138);
NM, 2.2% (3/138); and SM, 0.7% (1/138). None of these
138 isolates were resistant to GM, CM or CL. Notably,
tetracycline resistance was also detected in over 80% of
Table 1 Numbers of C. jejuni isolates and two most common Lior serotypes by study location/year
Year Study location Enrolled diarrhea cases Number of C. jejuni isolates Two most common Lior serotypes
(Total = 1292) (Total = 312) (Number of isolates)
1998 Kanjanaburi 166 10 HL: 11 (3), HL: 36 (2)
Cholburi 12 HL: 36 (3), HL: 11 (2)
1999 Korat 198 84 HL: 36 (33), HL: 19 (15)
2000 Nakornsrithammarat 256 68 HL: 11 (23), HL: 36 (19)
2001 Phitsanulok 153 54 HL: 5 (11), HL: 36 (8)
2001-2002 Bangkok 417 46 untypable (35), HL:11 (5)
2002 Sakaew 54 15 HL: 36 (7), untypable (4)
2003 Pranburi 48 23 HL: 4 (7), HL: 36 (3)
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Page 2 of 11isolates that were similar to C. jejuni isolates from
Taiwan (95%) [27], Korea (87%) [6,28], Canada, and the
U.S. (50%) [29,30].
The two most common resistance patterns observed
in these 138 isolates were multiple resistance to four
antimicrobials (NAL, CIP, CF, and TE), observed in
79.0% (109/138) of the isolates, and multiple resistance
to five antimicrobials (NAL, CIP, CF, TE, and SXT),
detected in 47.8% (66/138) of the isolates. Another resis-
t a n c ep a t t e r n( N A L ,C I P ,C F ,T E ,S X T ,a n dA M P )w a s
found in 15.9% (22/138) of the isolates, and a fourth
pattern of resistance (NAL, CIP, CF, TE, and KM) was
detected in 5.8% (8/138) of the isolates. The first com-
mon pattern was similar to a previous report of antimi-
crobial resistance to NAL, CIP, and TE in 53% of
clinical C. jejuni isolates in Thailand [31]. These results
confirm widespread quinolone and tetracycline resis-
tance among C. jejuni isolates from traveler’s diarrhea in
Thailand.
Antimicrobial resistance by study location and the
results of the chi-square test are shown in Table 3.
Interestingly, KM-resistant isolates were detected in
6.5% (9/138) of the isolates, but there was a significant
difference (from 2.2% to 21.8%) in the frequency of
resistance in isolates from different locations (p <
0.001). The percentage of AMP-resistant isolates also
varied by location (p < 0.05). The resistance of isolates
to SXT varied greatly from 90.7% at Phitsanulok to
58.7% at Bumrungrad Hospital, 26.7% at Sakaew, and to
undetectable levels in isolates from Pranburi (p < 0.001).
The finding of differences in AMP, KM, and SXT
resistance among C. jejuni isolates from selected sites
should not be considered as indicative of significant
changes over time in Thailand.
In this study, the antimicrobial susceptibility tests
were performed by disk diffusion assay. Other methods,
including agar dilution and broth micro dilution meth-
ods, and epsilometer test (E-tests) have been used by
different laboratories to measure antimicrobial suscept-
ibilities for Campylobacter spp. [32-35]. However, good
agreement of antimicrobial susceptibility test between
disk diffusion and agar dilution tests has been observed
in several classes of antimicrobials especially quinolone/
fluoroquinolones and aminoglycosides suggesting that
disk diffusion test could be used as qualitative assay but
not quantitative assay for antimicrobial susceptibility
among Campylobacter spp. [36]. Although another
study suggested that interpretation of erythromycin by
disk diffusion assay was unreliable and should be con-
firmed by MIC-based methods [37], but our previous
data showed high correlation of antimicrobial suscept-
ibility by disk diffusion and agar dilution tests in
erythromycin and azithromycin-resistant C. jejuni and
C. coli isolates [38].
PFGE and antimicrobial resistance by study location
Dendrograms A thru D in Figs. 2, 3, 4, and 5 were gen-
erated for four study locations from 2001-2003. Dendro-
gram A includes 46 isolates obtained from Bumrungrad
Hospital, Bangkok, over the two-year period from 2001-
2002 (Figure 2). Although the common resistance pat-
tern (NAL, CIP, CF, and TE) was observed in 76.1%
Table 2 Lior serotype distribution of C. jejuni isolates among foreign travelers and U.S. military personnel (1998-2003)
Lior serotype Serotypes in foreign travelers % (n) Serotypes in U.S. military personnel % (n) % Total (n)
(Total = 46) (Total = 266) (Total = 312)
HL: 36 6.5 (3) 28.2 (75) 25.0 (78)
HL: untypable 54.3 (25) 11.7 (30) 17.6 (55)
HL: 11 6.5 (3) 14.7 (40) 13.8 (43)
HL: 5 4.3 (2) 7.9 (21) 7.4 (23)
HL: 1 0.0 7.5 (19) 6.1 (19)
HL: 4 4.3 (2) 5.6 (15) 5.4 (17)
HL: 19 0.0 6.0 (17) 5.4 (17)
HL: 7 2.2 (1) 4.9 (13) 4.5 (14)
HL: 114 4.3 (2) 4.1 (10) 3.8 (12)
HL: 28 4.3 (2) 3.8 (10) 3.8 (12)
HL: 102 2.2 (1) 1.9 (5) 1.9 (6)
HL: 2 0.0 1.9 (5) 1.6 (5)
HL: 9 0.0 1.5 (4) 1.3 (4)
HL: 17 4.3 (2) 0.4 (1) 1.0 (3)
HL: 41 2.2 (1) 0.0 0.3 (1)
HL: 53 0.0 0.4 (1) 0.3 (1)
HL: 6 2.2 (1) 0.0 0.3 (1)
HL: 86 2.2 (1) 0.0 0.3 (1)
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Page 3 of 11Figure 1 Dendrogram and Lior serotype of 312 C. jejuni isolates from travelers’ diarrhea in Thailand (1998-2003). PFGE cluster analysis
of a SmaI/KpnI restriction enzyme digest of genomic DNA from 312 C. jejuni isolates analyzed at an 80% similarity cut off, resulting in 62
genotypes distributed between Lior serotypes.
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Page 4 of 11(35/46) of the isolates, there was substantial heterogene-
ity in the PFGE patterns (Figure 2). The PFGE analysis
suggests diverse genotypes. No specific multi-resistant
antimicrobial patterns were noted in the remainder of
these isolates. The dendrogram and the diversity of ser-
otypes and antimicrobial susceptibility patterns suggest
that these isolates are heterogeneous and clonally
diverse.
Dendrogram B includes the 54 isolates collected from
U.S. soldiers in Phitsanulok in 2001 (Figure 3). As
above, 87% (47/54) of these isolates were generally
multi-resistant to NAL, CIP, CF, and TE; in addition,
87% (47/54) were resistant to NAL, CIP, CF, and SXT.
The genotype B3 included 24 isolates exhibiting 86.1%
similarity that belonged to three serotypes: HL: 5 (11),
HL: 102 (3), and HL: untypable (10). A subset of 12 iso-
lates (B3a) within the genotype B3 had 99.7% similarity
and resistance to AMP, suggesting clonality (Figure 3).
Similarly, genotype B1 consisted of five isolates of sero-
type HL: 36 with 100% similarity and an identical anti-
microbial resistance pattern (NAL, CIP, CF, TE, and
SXT). C. jejuni isolates in genotypes B1 and B3a were
isolated over a 5-day period and 8-day period,
respectively.
Dendrogram C (Figure 4) shows 15 isolates collected
from U.S. soldiers in Sakaew over a 1-month period in
2002. Genotype C1 includes 5 isolates of serotype HL:
36 with 99.2% similarity and an identical antimicrobial
resistance pattern (NAL, CIP, CF, AMP, and TE), which
also suggests clonality. The other 10 isolates had <67.5%
similarity and included five serotypes and seven antimi-
crobial resistance patterns, suggesting more diverse
sources (Figure 4). All C. jejuni isolates in genotype C1
were isolated over a period of 6 days.
Dendrogram D (Figure 5) shows the 23 isolates col-
lected from U.S. soldiers in Pranburi during a 1-month
exercise in 2003 and genotype D1 includes a unique
cluster of five serotype HL: 4 isolates with an unusual
multi-resistant antimicrobial pattern (NAL, CIP, CF,
KM, and TE), suggesting clonality for these isolates.
Similar to dendrograms B and C, genotype D1 included
C. jejuni isolates collected during a 10-day period.
Conclusions
In summary, our study demonstrates the usefulness of
PFGE in local epidemiological studies or in the study of
small outbreaks occurring over a short time interval
rather than in the long-term epidemiological studies
that have been studied by others [26]. This study con-
firmed the existence of common C. jejuni clones that
are associated with specific serotypes and multiple anti-
microbial resistance patterns in the Cobra Gold military
exercises but not in the traveler’s diarrhea study at
Bumrungrad Hospital. A possible explanation for these
findings is that the Cobra Gold military exercises took
place at particular locations with short durations (1
month). Diarrhea cases among soldiers might also be
expected to be caused by common exposures. Our find-
ing of an association between PFGE and serotype with
the antimicrobial resistance patterns in these exercises
differed from other studies in which the correlation
between PFGE and multi-antimicrobial resistance was
low [28,39,40]. In the Bumrungrad Hospital study,
where diarrhea cases occurred in diverse populations
Table 3 Antimicrobial resistance among 138 human C. jejuni isolates from Thailand (2001-2003)
Antimicrobial Percentage of resistant isolates (number of isolates)
Phitsanulok 2001
(n = 54)
Bangkok 2001-2002
(n = 46)
Sakaew 2002
(n = 15)
Pranburi 2003
(n = 23)
p-value *
Nalidixic acid 96.2% (52) 93.5% (43) 86.6% (13) 100.0% (23) NS
Ciprofloxacin 96.2% (52) 87.0% (40) 86.6% (13) 91.3% (21) NS
Erythromycin 0.0% (0) 6.5% (3) 0.0% (0) 0.0% (0) NS
Azithromycin 0.0% (0) 6.5% (3) 0.0% (0) 0.0% (0) NS
Tetracycline 90.7% (49) 76.0% (35) 86.6% (13) 69.5% (16) NS
Trimethoprim-
sulfamethoxazole
90.7% (49) 58.7% (27) 26.7% (4) 0.0% (0) <0.001
Ampicillin 31.5% (17) 30.4% (14) 60.0% (9) 8.7% (2) <0.05
Kanamycin 0.0% (0) 2.2% (1) 20.0% (3) 21.8% (5) <0.001
Sulfisoxazole 0.0% (0) 10.9% (5) 0.0% (0) 0.0% (0) NA
Neomycin 0.0% (0) 2.2% (1) 1.7% (1) 1.7% (1) NA
Streptomycin 0.0% (0) 0.0% (0) 1.7% (1) 0.0% (0) NA
Gentamicin 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) NA
Colistin 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) NA
Chloramphenicol 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) NA
Cephalothin 100.0% (52) 100.0% (60) 100.0% (15) 100.0% (23) NA
* Pearson chi-square Monte Carlo (two-tailed); NS, non-significant; NA, not applicable.
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Page 5 of 11Figure 2 Dendrogram of C. jejuni isolates with Lior serotypes and antimicrobial resistance from Bumrungrad Hospital (2001-2002).
Dendrogram A: PFGE cluster analysis of a SmaI/KpnI restriction enzyme digest of genomic DNA from 46 C. jejuni isolates with marked clonal
heterogeneity, unrelated antimicrobial resistance patterns, and 25 untypable isolates from this study site. R, resistance; I, intermediate
susceptibility; S, susceptible; ND, not tested.
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Page 6 of 11Figure 3 Dendrogram of 54 C. jejuni isolates with Lior serotypes and antimicrobial resistance from Phitsanulok 2001.D e n d r o g r a mB :
PFGE cluster analysis of a SmaI/KpnI restriction enzyme digest of genomic DNA from 54 C. jejuni isolates from the Cobra Gold exercises
(Phitsanulok, 2001) with evidence of clonality due to similarity in the PFGE patterns, Lior serotype(s) and related specific antimicrobial
susceptibility patterns (genotypes B1 and B3a). R, resistance; I, intermediate susceptibility; S, susceptible.
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Page 7 of 11over a 2-year period, a similar low correlation was
observed between serotype and antimicrobial resistance.
Our data suggest that these patients became infected
with unrelated C. jejuni isolates. Comprehensive moni-
toring of human C. jejuni isolates, including animal and
environmental sources, should be expanded in Thailand
to monitor antimicrobial resistance and to better docu-
ment potential sources of infection.
Methods
Sources of isolates
Under approved human use protocols, stool specimens
were obtained from patients with diarrhea and from
asymptomatic controls in an acute diarrhea study
among foreign travelers from highly developed countries
at Bumrungrad Hospital in Bangkok, Thailand during
2001-2002. Stool specimens were collected from U.S.
Figure 4 Dendrogram of 15 C. jejuni isolates with Lior serotypes and antimicrobial resistance from Sakaew 2002. Dendrogram C: PFGE
cluster analysis of a SmaI/KpnI restriction enzyme digest of genomic DNA of 15 C. jejuni isolates from the Cobra Gold exercises (Sakaew, 2002)
with evidence of clonality due to similarity in the PFGE patterns (>99.2%), identical Lior serotype (HL:36) and a specific antimicrobial susceptibility
pattern (genotype C1 with ampicillin resistance). R, resistance; S, susceptible.
Figure 5 Dendrogram of 23 C. jejuni isolates with Lior serotypes and antimicrobial resistance from Pranburi 2003. Dendrogram D: PFGE
cluster analysis of a SmaI/KpnI restriction enzyme digest of genomic DNA of 23 C. jejuni isolates from the Cobra Gold exercises (Pranburi, 2003)
with evidence of clonality due to similarity in the PFGE patterns (100%), identical Lior serotype (HL: 4) and specific antimicrobial susceptibility
patterns (genotype D1 with additional kanamycin resistance). R, resistance; I, intermediate susceptibility; S, susceptible.
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Page 8 of 11soldiers with acute diarrhea and from asymptomatic
controls; the soldiers were deployed for the Cobra Gold
exercises lasting one for four weeks at different sites in
Thailand during 1998-2003. Only C. jejuni isolates from
acute diarrhea cases were included in this study. Table 1
describes the number of C. jejuni isolates from cases in
each study location.
Isolation and identification
All stool specimens were cultured for Campylobacter
spp. using a modified filtration method described pre-
viously [41]. Suspected colonies, growing on Brucella
Agar (Difco, Detroit, MI, USA) with 5% sheep blood
(BAP), were identified as Campylobacter spp. by colony
characteristics, Gram staining, oxidase tests, and catalase
tests, followed by phenotypic tests including hippurate
hydrolysis, nitrate reduction, H2S TSI, oxygen tolerance,
and microaerobic growth at 25°C, 37°C, and 42°C.
C. jejuni isolates were differentiated from C. coli by the
hippurate hydrolysis test. All C. jejuni isolates were kept
in glycerol medium at -70°C for further analysis.
Serotyping
Lior serotyping was performed by an agglutination assay
with specific antiserum obtained from the National
Laboratory for Enteric Pathogens (NLEP) in Winnipeg,
Manitoba, Canada. These antisera were routinely used
to serotype C. jejuni and C. coli isolates at AFRIMS.
The antisera detect heat-labile antigens [9] and identify
33 common HL serotypes.
Antimicrobial susceptibility testing
C. jejuni isolates were tested for susceptibility to antimi-
crobial drugs using a disk diffusion assay as described
previously [42], with modifications. BAP subcultures of
patient isolates at 18- to 48-h were suspended in Muel-
ler Hinton broth (BD Diagnostic Systems, Sparks, MD,
USA.) to obtain a turbidity equivalent to a 1.0 McFar-
land standard, and suspensions were inoculated onto
Mueller Hinton II agar supplemented with 5% sheep
blood. At the time of each study, all C. jejuni isolates
were tested for susceptibility to the following antimicro-
bials (BD Diagnostic Systems): NAL (30 μg), CIP (5 μg),
ERY (15 μg), and AZM (15 μg). The 138 C. jejuni iso-
lates in 2001-2003 were further tested for susceptibility
to 11 additional antimicrobials by disk diffusion assay.
These antimicrobial disks included AMP (10 μg), CM
(30 μg), KM (30 μg), GM (10 μg), SM (10 μg), TE (30
μg), SXT (1.25/23.75 μg), SU (250 μg), CL (10 μg), NM
(30 μg), and CF (30 μg). Disks were placed on the sur-
faces of inoculated Mueller Hinton II agar plates. Inocu-
lated plates were incubated at 37°C for 24 h in a
microaerobic environment. The plates were re-incubated
up to 48 h if insufficient growth of C. jejuni isolates on
the Muller Hinton II agar plates was obtained at 24 h.
Because no standardized interpretive criteria exist for
Campylobacter spp., the inhibition zone diameters were
measured and interpreted following the disk manufac-
turer’s instructions and compared against the Clinical
and Laboratory Standards Institute (formerly NCCLS)
standard guidelines for aerobic gram-negative bacilli to
interpret the results as susceptible, intermediate, or
resistant [43]. Escherichia coli ATCC 25922 and Staphy-
lococcus aureus ATCC 25923 were used as standard
organisms for all disk diffusion assays.
Statistical analysis
Pearson’s chi-square tests of independence for the anti-
microbial susceptibility data (NAL, CIP, ERY, AZM, TE,
SXT, AMP, and KM) between locations were performed
using the Monte Carlo-exact (2-sided) method in SPSS
v e r s i o n1 2 . 0( S P S SI n c . ,C h i c a g o ,I L ,U S A ) .Ap - v a l u e
< 0.05 was considered significant.
PFGE
PFGE was performed according to the One-Day (24-28
h) Standardized Laboratory Protocol for Molecular Sub-
typing by the CDC [12] with the minor modifications
described below. The cell density of each isolate was
adjusted to an O.D. of 0.6 using a spectrophotometer
(Spectramax 190; Molecular Devices, Sunnyvale, CA,
USA) that was different from the spectrophotometers
suggested by the CDC. The PFGE patterns were ana-
lyzed to generate dendrograms of the combined SmaI
and KpnI similarities using BioNumerics version 5.0
(Applied Maths, Sint-Martens-Latem, Belgium) by
UPGMA type and Dice coefficient with 1.5% optimiza-
tion and tolerance. Dendrograms were made for the
composite data of all of the C. jejuni isolates and for the
different locations.
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